Published • loading... • Updated
₹50 Lakh Short for an Injection Worth ₹9.50 Crore: Anika's Treatment Is Being Delayed; the High Court Gives the Government Time to Respond.
Summary by Dainik Bhaskar
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
The family of Indore's Anika Sharma, who suffers from a rare disease, has so far raised ₹8.53 crore for her treatment. Zolgenerma gene therapy injections, worth approximately ₹9.50 crore, are to be procured from the United States. However, the wait for treatment is growing longer due to a lack of the necessary funds. The family needs to raise approximately ₹50 lakh more. The matter regarding the potential ₹50 lakh in aid from the central governm…
·Bhopal, India
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
